Left ventricular assist devices and bleeding: adding insult to injury

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Transplantation Medicine

Background:

• Bleeding is the most frequent postoperative complication after left ventricular assist device (LVAD) implantation, occurring in up to 60% of patients.
• Massive blood transfusions associated with bleeding complications carry significant risks, including infection, pulmonary insufficiency, allosensitization, and potentially fatal outcomes.
• Effective management of bleeding is crucial for successful LVAD therapy and bridging patients to transplantation.

Purpose of the Study:

• To highlight the critical importance of managing postoperative bleeding in left ventricular assist device recipients.
• To emphasize the need for strategic preoperative and intraoperative interventions to minimize bleeding complications.
• To advocate for the adoption of standardized protocols for achieving "hemostatic readiness" in LVAD therapy.

Main Methods:

• Review of existing literature and clinical practices concerning bleeding complications in LVAD patients.
• Analysis of the risks associated with massive blood transfusions post-LVAD implantation.
• Discussion of essential components of preoperative evaluation, intraoperative hemostasis, and avoidance of indiscriminate product replacement.

Main Results:

• Postoperative bleeding is a pervasive issue in LVAD therapy, often requiring reoperation.
• Associated complications of blood transfusions are numerous and can be life-threatening.
• Strategic management, including preoperative assessment and intraoperative hemostasis, is vital.

Conclusions:

• Adherence to protocols focused on "hemostatic readiness" can substantially decrease bleeding complications in LVAD patients.
• Improved bleeding management can enhance the success rates of LVAD therapy, particularly in bridging patients to heart transplantation.
• A proactive approach to hemostasis is essential for optimizing LVAD patient care and outcomes.